R
Richard J. Colonno
Researcher at Bristol-Myers Squibb
Publications - 146
Citations - 14924
Richard J. Colonno is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Entecavir & Hepatitis B virus. The author has an hindex of 57, co-authored 141 publications receiving 14236 citations. Previous affiliations of Richard J. Colonno include Hoffmann-La Roche.
Papers
More filters
Journal ArticleDOI
LBP-12-Phase 1a Study of the Safety, Tolerability and Pharmacokinetics of ABI-H, a Novel Second-Generation HBV Core Inhibitor, in Healthy Volunteers
Edward Gane,Christian Schwabe,Marc Evanhcik,Eric Ruby,Sandy Liaw,Katia Alves,Richard J. Colonno,Uri Lopatin +7 more
Journal ArticleDOI
43 Absence of entecavir resistance emergence in lamivudine-refractory patients treated for at least one year with entecavir in study A1463-014
Journal ArticleDOI
O65 high rate of sustained virologic response in patients with hcv genotype-1a infection: a phase 2 trial of faldaprevir, deleobuvir and ppi-668, with and without ribavirin
Jacob Lalezari,L. Holland,E. Glutzer,P. Vig,M. Elgadi,J.O. Stern,Richard J. Colonno,S. Halfon,Eric Ruby,N. Huang,E. Nash,Nathaniel A. Brown +11 more
Journal ArticleDOI
PS-073-Preclinical profile of HBV core protein inhibitor, ABI-H, a potent inhibitor of cccDNA generation in HBV infected cells
Qi Huang,Haydar Simon,Yi Zhou,Dawei Cai,Xiang Xu,Ran Yan,Lida Guo,Esteban Carabajal,Xuman Tang,Walker Michael,Rai Roopa,Mark Bures,Li Leping,Richard J. Colonno +13 more
Journal ArticleDOI
1192 vast majority of detected ns5a resistant variants are not amplified in hcv patients during 3-day monotherapy with the optimized ns5a inhibitor ppi-668
Qi Huang,N. Huang,A. Huq,M. Lau,E. Peng,Jacob Lalezari,G. Farrell,P. Shah,E.J. Lawitz,P. Vig,Nathaniel A. Brown,Richard J. Colonno +11 more